BioXcel Therapeutics Inc logo

BioXcel Therapeutics Inc

FRA:BX2 (USA)  
€ 2.37 (-1.62%) Apr 30
At Loss
Market Cap:
€ 71.91M ($ 76.63M)
Enterprise V:
€ 105.66M ($ 112.59M)
Volume:
-
Avg Vol (2M):
4.37K
Also Trade In:

BioXcel Therapeutics Inc Operating Data

BioXcel Therapeutics Inc Competitors' Latest Operating Data

Operating data not available.

BioXcel Therapeutics Inc (FRA:BX2) Operating Data Charts